This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Michael L. Smith, R.R.T., J.D., Board Certified by The Florida Bar in Health Law, and George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. On April 8, 2013, a Los Angeles jury awarded $3.8 million in compensatory damages to an urgent care and family practice physician who claimed he was wrongly excluded from Anthem Blue Cross’s provider network.
By Catherine T. Hollis, J.D., The Health Law Firm. The Orlando Sentinel reports that in April 2013 , the Florida Department of Law Enforcement (FDLE) named local undercover detective Billy Powell of the Metropolitan Bureau of Investigation (MBI) in Orlando as its Special Agent of the Year. Powell received this award for his outstanding efforts in pill mill investigations.
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. The US Food and Drug Administration (FDA) sent out a warning to health care professionals that steroid injections compounded by Main Street Family Pharmacy, LLC, in Tennessee, may be contaminated. The announcement came on May 24, 2013. So far, seven patients have allegedly suffered adverse reactions from the medications.
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. From our experience mental health counselors, psychologists, social workers and family therapists are at a high risk of having a client or patient file a complaint against them with their licensing board. Many of their clients/patients have mental health problems, emotional problems or personality disorders; this is why they are seeing a therapist to begin with.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. Johnson and Johnson’s DePuy Orthopaedics announced on May 16, 2013, that the company is phasing out all of its metal-on-metal and ceramic-on-metal hip replacements. As of August 31, 2013, these DePuy products will no longer be available worldwide. Click here to read the press release from DePuy Orthopaedics.
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. Novartis Pharmaceuticals Corporation (NPC) is currently fielding two different lawsuits, filed just days apart from each other, by the US Department of Justice (DOJ). The first lawsuit was filed on April 23, 2013, alleging the company gave illegal kickbacks to pharmacists.
By Carole C. Schriefer, R.N., J.D., The Health Law Firm and George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. Two nationwide recalls of metal-on-metal hip implants by Johnson and Johnson’s DePuy Orthopaedics and Stryker Orthopaedics has prompted The Health Law Firm to take on plaintiffs’ products liability cases against these manufacturers.
40
40
Sign up to get articles personalized to your interests!
Health Care Compliance Brief brings together the best content for health law & compliance professionals from the widest variety of industry thought leaders.
By Carole C. Schriefer, R.N., J.D., The Health Law Firm and George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. Two nationwide recalls of metal-on-metal hip implants by Johnson and Johnson’s DePuy Orthopaedics and Stryker Orthopaedics has prompted The Health Law Firm to take on plaintiffs’ products liability cases against these manufacturers.
By Lance O. Leider, J.D., The Health Law Firm. There’s been yet another recall from a compounding pharmacy. On May 8, 2013, the US Food and Drug Administration (FDA) sent a warning to doctors and pharmacists to avoid drugs made by The Compounding Shop, based in St. Petersburg, Florida. The recall is due to potential safety concerns. Click here to read the press release from the FDA.
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. A Miami patient recruiter will spend the next 37 months in prison for his part in a $20 million Medicare fraud scheme, according to the Department of Justice (DOJ). Manuel Lozano was sentenced on May 6, 2013, in the Southern District of Florida. In addition to his prison sentence, Mr.
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law and Carole C. Schriefer, R.N., J.D., The Health Law Firm. The Health Law Firm has recently undertaken plaintiffs’ products liability cases against the manufacturers of defective hip implants, including both Johnson and Johnson’s DePuy Orthopaedics and Stryker Orthopaedics implants.
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. The future of Florida’s prescription drug monitoring program looked bleak going into the last day of the legislative session. However, on May 3, 2013, lawmakers voted to fund the prescription drug database for one year, according to the Orlando Sentinel.
Based on comprehensive survey data from diverse healthcare providers, the 2025 HIPAA Benchmark Report delivers actionable intelligence for modern compliance programs. This report examines how organizations are restructuring HIPAA Privacy Programs to address emerging regulatory requirements. Through analysis of staffing models, program operations, and breach management protocols, it provides a clear picture of current best practices.
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law and Carole C. Schriefer, R.N., J.D., The Health Law Firm. In August 2010, Johnson and Johnson’s DePuy Orthopaedics recalled 93,000 ASR XL hip implants after a significant percentage failed within five years. ( Click here to read the press release from DePuy.
40
40
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content